Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Suarez-Almazor

Showing results (111-120 of 243) with videos related to

Pageof 25
Sort By:
BMC Rheumatology|February 10, 2026
Preferences, experiences and needs regarding tobacco cessation expressed among patients with rheumatoid arthritis: a qualitative studyMaria A Lopez-Olivo, Sheneze Madramootoo, Johncy J Kachira, et al.
Arthritis Care & Research|November 22, 2017
Treating Early Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Direct and Indirect Trial EvidenceMaria A Lopez-Olivo, Voke Kakpovbia-Eshareturi, Jude K des Bordes, et al.
BMJ Oncology|January 31, 2025
Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitorsCarrie Ye, Bo Zhao, William D Leslie, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 10, 2020
Preferred Strategies for Delivering Health Information to Patients With Musculoskeletal Disorders: A Qualitative StudyMaria A Lopez-Olivo, Jude K A des Bordes, Maria Jibaja-Weiss, et al.
Journal for Immunotherapy of Cancer|May 16, 2019
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flareSang T Kim, Mohamad Bittar, Hyun J Kim, et al.
Journal of Health Communication|September 19, 2017
Online Educational Tool to Promote Bone Health in Cancer SurvivorsJude K A des Bordes, Maria E Suarez-Almazor, Robert J Volk, et al.
The Journal of Rheumatology|June 3, 2010
The symptom burden index: development and initial findings from use with patients with systemic sclerosisMichael A Kallen, Maureen D Mayes, Yana L Kriseman, et al.
Clinical Rheumatology|August 18, 2020
Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapyXerxes Pundole, Natalia V Zamora, Harish Siddhanamatha, et al.
Clinical Rheumatology|September 4, 2024
Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancerMaria E Suarez-Almazor, Juan I Ruiz, Xiudong Lei, et al.
ACR Open Rheumatology|November 29, 2019
Real-World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid ArthritisKaleb Michaud, Bernard Vrijens, Eric Tousset, et al.
Pageof 25

Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
BMC Rheumatology|February 10, 2026
Preferences, experiences and needs regarding tobacco cessation expressed among patients with rheumatoid arthritis: a qualitative studyMaria A Lopez-Olivo, Sheneze Madramootoo, Johncy J Kachira, et al.
Arthritis Care & Research|November 22, 2017
Treating Early Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Direct and Indirect Trial EvidenceMaria A Lopez-Olivo, Voke Kakpovbia-Eshareturi, Jude K des Bordes, et al.
BMJ Oncology|January 31, 2025
Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitorsCarrie Ye, Bo Zhao, William D Leslie, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 10, 2020
Preferred Strategies for Delivering Health Information to Patients With Musculoskeletal Disorders: A Qualitative StudyMaria A Lopez-Olivo, Jude K A des Bordes, Maria Jibaja-Weiss, et al.
Journal for Immunotherapy of Cancer|May 16, 2019
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flareSang T Kim, Mohamad Bittar, Hyun J Kim, et al.
Journal of Health Communication|September 19, 2017
Online Educational Tool to Promote Bone Health in Cancer SurvivorsJude K A des Bordes, Maria E Suarez-Almazor, Robert J Volk, et al.
The Journal of Rheumatology|June 3, 2010
The symptom burden index: development and initial findings from use with patients with systemic sclerosisMichael A Kallen, Maureen D Mayes, Yana L Kriseman, et al.
Clinical Rheumatology|August 18, 2020
Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapyXerxes Pundole, Natalia V Zamora, Harish Siddhanamatha, et al.
Clinical Rheumatology|September 4, 2024
Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancerMaria E Suarez-Almazor, Juan I Ruiz, Xiudong Lei, et al.
ACR Open Rheumatology|November 29, 2019
Real-World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid ArthritisKaleb Michaud, Bernard Vrijens, Eric Tousset, et al.
Pageof 25